Correlation Between Telkom Indonesia and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Telkom Indonesia and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telkom Indonesia and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telkom Indonesia Tbk and Travere Therapeutics, you can compare the effects of market volatilities on Telkom Indonesia and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telkom Indonesia with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telkom Indonesia and Travere Therapeutics.
Diversification Opportunities for Telkom Indonesia and Travere Therapeutics
-0.65 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Telkom and Travere is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding Telkom Indonesia Tbk and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Telkom Indonesia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telkom Indonesia Tbk are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Telkom Indonesia i.e., Telkom Indonesia and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Telkom Indonesia and Travere Therapeutics
Considering the 90-day investment horizon Telkom Indonesia Tbk is expected to under-perform the Travere Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Telkom Indonesia Tbk is 1.72 times less risky than Travere Therapeutics. The stock trades about -0.06 of its potential returns per unit of risk. The Travere Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 1,750 in Travere Therapeutics on September 1, 2024 and sell it today you would earn a total of 131.00 from holding Travere Therapeutics or generate 7.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Telkom Indonesia Tbk vs. Travere Therapeutics
Performance |
| Timeline |
| Telkom Indonesia Tbk |
| Travere Therapeutics |
Telkom Indonesia and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Telkom Indonesia and Travere Therapeutics
The main advantage of trading using opposite Telkom Indonesia and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telkom Indonesia position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Telkom Indonesia vs. T Mobile | Telkom Indonesia vs. Comcast Corp | Telkom Indonesia vs. Lumen Technologies | Telkom Indonesia vs. Charter Communications |
| Travere Therapeutics vs. Tff Pharmaceuticals | Travere Therapeutics vs. Eliem Therapeutics | Travere Therapeutics vs. Inhibrx | Travere Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |